Improved clinical outcome measures of knee pain and function with concurrent resolution of subchondral Bone Marrow Edema Lesion and joint effusion in an osteoarthritic patient following Pentosan Polysulphate Sodium treatment: a case report
Crossref DOI link:
Published Online: 2017-09-12
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sampson, Matthew J.
Funding for this research was provided by:
The drug, Pentosan Polysulphate Sodium, was supplied by Paradigm BioPharmaceuticals Ltd. (NA)